Sensitivity and Specificity of the Clinical Classifications Generated by the Cureety Digital Telemonitoring Tool (POSITEA-VA)

Cureety

Status: Completed

Conditions: Neoplasms

Treatments: Device: Cureety TechCare

Study type: Observational

Funder types: Industry

Identifiers

NCT05653609

CTC-2022-11-A

Details and patient eligibility

About

Cureety is a digital telemonitoring platform specifically designed to monitor cancer patients through self-reporting of adverse events, accompany patients and their medical teams and complement existing healthcare practices. The platform aims to detect signs and symptoms of health deterioration and disease progression, allowing the medical team to intervene earlier than usual compared to conventional care.

The patients are asked to respond to an electronic patient-reported outcome (ePRO) questionnaire. The digital tool is configured for each patient that generates specific questions that allow grading of adverse events relevant to their specific treatment and disease profile.

At the core of the platform is the medical device "Cureety TechCare", an algorithm that outputs a "clinical classification" based on the adverse events reported by the patients. There are four levels that correspond to the patients' health states, either "critical" ("red"), "to be monitored" ("orange"), "compromised" ("yellow"), or "correct" ("green"). In the case of a red or orange classification, the patients are asked to contact their medical team. In addition, the medical team can monitor the patient classifications from a distance including receiving notifications when patients are classified red and orange.

The present study was designed to retrospectively evaluate the performance of the "Cureety TechCare" medical device in real-life using data collected in the Cureety database.

Enrollment: 400 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Male or female aged 18 years or older.
• Patients that have completed at least one questionnaire in Cureety
• Patients that have not exercised their right to oppose to the use of their data for clinical research.

Exclusion criteria

• N/A

Trial design

400 participants in 1 patient group

Telemonitoring

Description:

Patients monitored by the Cureety digital platform

Treatment:

Device: Cureety TechCare